This Asthma Drug Can Half Chance Of Suffering Severe Asthma Attack

By Sona Kadam on September 5, 2016 at 2:11 PM

- - Advertisement - -

As per the recent reports a new asthma drug which can half the chance of suffering a severe attack could prevent hundreds of deaths a year. Monthly injections of benralizumab were found to reduce episodes of serious shortness of breath, wheezing and chest tightness by up to 51 per cent.

Benralizumab jabs prevented severe flare-ups of asthma which could no longer be controlled with high dose steroid inhalers and other drugs.

Two trials, Calima and Sirocco, compared the effects of benralizumab and a dummy placebo treatment in more than 2,500 patients with severe asthma.

But two trials on more than 2,500 patients showed that the benralizumab could offer new hope for people whose asthma can no longer be controlled by steroid inhalers and other drugs.

“Patients with severe, uncontrolled asthma have very few treatment options once they are already taking high-dose inhaled corticosteroids and long-acting beta agonists,” said Professor Eugene Bleecker, Centre for Genomics and Personalised Medicine, Wake Forest School of Medicine, who led one of the trials.

The findings are published in The Lancet medical journal and were presented at the European Respiratory Society’s annual meeting in London.